glp 1 agonist bone density Frontiers GLP‑1 Bone Health: Risk or

Because CVD is the leading cause of death in patients with type 2 diabetes (T2D), T2D is often referred as a 'cardiovascular disease (CVD)' [1]

AMG 133 Phase I results Are GLP-1 Weight Loss Drugs the Next Blockbusters

Particulate gastric contents in patients prescribed glucagon-like peptide 1 receptor agonists after appropriate perioperative fasting: a report of 2 cases

Also, the adverse cardiovascular safety in clinical trials before 2008 was evaluated based on populations that were not necessarily at high risk of cardiovascular disease and the follow-up duration was relatively short (usually less than 12 months)

Typical effective doses range from 400-800mg of EGCG daily, equivalent to roughly 8-16 cups of green tea, which is why supplementation makes more sense than drinking the tea directly